Letter by Kuwabara Regarding Article, "Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study"

Circulation. 2019 Mar 5;139(10):1348-1349. doi: 10.1161/CIRCULATIONAHA.118.037976.

Author

Masanari Kuwabara¹

Affiliation

¹ Intensive Care Unit and Department of Cardiology, Toranomon Hospital, Tokyo, Japan.

PMID: 30830802
DOI: 10.1161/CIRCULATIONAHA.118.037976

No abstract available

Publication types

Letter
Comment

MeSH terms

Aged
Allopurinol
Cardiovascular Diseases*
Cohort Studies
Febuxostat
Gout Suppressants
Gout*
Humans
Patients
Population
Risk Factors

Substances

Gout Suppressants
Febuxostat
Allopurinol